It supports long-term weight loss and can also improve weight-related health conditions such as type 2 diabetes and high blood pressure
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B
Carriers seeking guidance on incorporating GLP-1 drugs into their underwriting framework are encouraged to contact Munich Re for support, particularly in leveraging comprehensive sources of evidence such as EHRs, where we can provide automated review and decisioning through solutions like alitheia
It is going to be a stellar time for people practicing in this field.
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsboll T, Warren ML, Bain SC